Precision medicine

BRAVEHeart – empowering breast cancer radiotherapy patients to save their hearts

More than 15,000 women in Australia were diagnosed with breast cancer in 2015. For more than 13,000 ...
Read more...

Developing a National Breast Cancer Database for Research and Service Delivery

This year breast cancer became the most commonly diagnosed cancer in Australia. Although it has one ...
Read more...

Improving decision-making for post-operative, postmenopausal women with oestrogen-receptor positive early breast cancer.

The vast majority of women with breast cancer have oestrogen-receptor positive tumours. After their ...
Read more...

Uncovering new treatments for metastatic triple negative breast cancer

Triple negative breast cancers are an aggressive subtype that lacks expression of the Estrogen and H ...
Read more...

Blocking a gene driving triple negative breast cancer

A primary driving force behind the start and ongoing development of breast cancer is the activation ...
Read more...

Expanding treatments for aggressive triple negative breast cancer

Triple negative breast cancer is an aggressive subtype of breast cancer. It has a 60% 5-year surviva ...
Read more...

Improving understanding of early breast cancer within the milk ducts

Ductal carcinoma in situ (DCIS) is a breast tumour contained within the breast milk ducts without ha ...
Read more...

Discovering a new path to treat advanced breast cancer

Certain types of breast cancer, such as triple negative breast cancer, are far more likely to spread ...
Read more...

Improving treatment and limiting side effects for metastatic breast cancer

Breast cancer is a leading cause of cancer-related deaths in women. Most of these deaths result from ...
Read more...

Understanding how changes in DNA drive breast cancer development

Cancer is driven by changes in DNA (mutations) that alter the behaviour of normal cells, making them ...
Read more...